2015
DOI: 10.1111/jvim.13576
|View full text |Cite
|
Sign up to set email alerts
|

Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs

Abstract: BackgroundAs in women, regional lymph node status impacts survival in dogs with malignant mammary tumors. However, few studies have evaluated regional lymph node metastases in dogs with malignant mammary gland tumors.ObjectivesTo estimate overall survival based on the assessments of the lymph node status and the morphologic and morphometric features in female dogs with malignant mammary gland tumors.Materials and MethodsIn total, 178 lymph nodes from 97 female dogs were assessed and reviewed, and after confirm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
30
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(35 citation statements)
references
References 41 publications
3
30
0
2
Order By: Relevance
“…Metastatic regional lymph nodes are an important negative prognostic factor in dogs with mammary tumors [18][19][20]. The association between an increase in the size of intraabdominal lymph nodes verified by ultrasonography and the presence of metastasis in superficial regional lymph nodes suggests that abdominal ultrasonography can help determine the metastatic potential of the mammary tumor prior to mastectomy.…”
Section: Discussionmentioning
confidence: 99%
“…Metastatic regional lymph nodes are an important negative prognostic factor in dogs with mammary tumors [18][19][20]. The association between an increase in the size of intraabdominal lymph nodes verified by ultrasonography and the presence of metastasis in superficial regional lymph nodes suggests that abdominal ultrasonography can help determine the metastatic potential of the mammary tumor prior to mastectomy.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is the first study to utilize increased step‐sections and panCK immunohistochemistry to identify various occult carcinoma metastases in regional lymph nodes within a veterinary cohort. In veterinary medicine, very few studies have assessed for the presence of micrometastases and isolated tumour cells in regional lymph nodes, and thus, a standardized approach for histologic and immunohistochemical evaluation and identification of small volume metastases is lacking, as is information regarding the prognostic significance of these foci.…”
Section: Discussionmentioning
confidence: 99%
“…Several large‐scale prospective studies, however, have documented significant differences in disease‐free survival, and overall survival, disease‐free survival and distant‐disease‐free‐survival in women with micrometastatic or occult metastatic lymph nodes, respectively, as compared with node‐negative patients. To our knowledge, only two studies have been conducted to evaluate the prognostic significance of regional lymph node status in dogs, both of which focused on canine mammary carcinomas . The variability in prognostic significance among these studies supports the need for future larger scale and prospective studies in veterinary medicine to both identify the presence of occult metastases in various types of carcinomas and to determine their prognostic significance with respect to recurrence and survival.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another example is the Framingham Heart Study, which utilized 12‐year follow‐up of >8,400 individuals to predict future cardiovascular disease based on age, smoking status, cholesterol, presence or absence of diabetes, and blood pressure 60. Predictive data such as these are increasingly available in veterinary patients across a variety of disease conditions, including neoplasia,61, 62, 63 cardiovascular disease,64, 65 and various diseases in horses66, 67 and cows 68. Incorporation of baseline risk in RCTs potentially can help estimate treatment effects in heterogeneous patient populations with greater accuracy and help clinicians select individuals that are most likely to experience treatment benefit.…”
Section: Risk: Baseline Relative and Absolutementioning
confidence: 99%